featured
Durvalumab Added to First-Line Carboplatin/Paclitaxel for Recurrent/Metastatic HNSCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: